Mesenchymal stem cells versus mesenchymal stem cells combined with cord blood for engraftment failure after autologous hematopoietic stem cell transplantation: a pilot prospective, open-label, randomized trial.

Xiong, Yi-Ying

Mesenchymal stem cells versus mesenchymal stem cells combined with cord blood for engraftment failure after autologous hematopoietic stem cell transplantation: a pilot prospective, open-label, randomized trial. [electronic resource] - Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation Feb 2014 - 236-42 p. digital

Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1523-6536

10.1016/j.bbmt.2013.11.002 doi


Adolescent
Adult
Chimerism
Female
Fetal Blood--cytology
Graft Rejection--immunology
Graft Survival--immunology
Hematopoietic Stem Cell Transplantation--adverse effects
Humans
Male
Mesenchymal Stem Cell Transplantation--adverse effects
Mesenchymal Stem Cells
Middle Aged
Prospective Studies
Transplantation, Autologous--adverse effects
Young Adult